publication . Article . 2011

Acamprosate and Baclofen were Not Effective in the Treatment of Pathological Gambling: Preliminary Blind Rater Comparison Study

Pinhas N. Dannon; Moshe Kotler; Oded Rosenberg; Netta Schoenfeld;
Open Access
  • Published: 01 Jun 2011 Journal: Frontiers in Psychiatry, volume 2 (eissn: 1664-0640, Copyright policy)
  • Publisher: Frontiers Media SA
Objectives: Pathological gambling (PG) is a highly prevalent and disabling impulse control disorder. A range of psychopharmacological options are available for the treatment of PG, including selective serotonin reuptake inhibitors, opioid receptor antagonists, anti-addiction drugs, and mood stabilizers. In our preliminary study, we examined the efficacy of two anti-addiction drugs, baclofen and acamprosate, in the treatment of PG. Materials and Methods: Seventeen male gamblers were randomly divided into two groups. Each group received one of the two drugs without being blind to treatment. All patients underwent a comprehensive psychiatric diagnostic evaluation a...
free text keywords: Psychiatry and Mental health, Clinical Trial, pathological gambling, GABA, RC435-571, Internal medicine, medicine.medical_specialty, medicine, Psychology, Comparison study, Psychiatry, Impulse control disorder, medicine.disease, Baclofen, chemistry.chemical_compound, chemistry, Acamprosate, medicine.drug, Mood, Behavioral addiction, medicine.symptom, Pathological, Abstinence, media_common.quotation_subject, media_common
Related Organizations
23 references, page 1 of 2

Addolorato G.Leggio L.Agabio R.Colombo G.Gasbarrini G. (2006). Baclofen: a new drug for the treatment of alcohol dependence. Int. J. Clin. Pract. 60, 1003–1008 16893442 [PubMed]

Addolorato G.Leggio L.Cardone S.Ferrulli A.Gasbarrini G. (2009). Role of the GABA (B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives. Alcohol 43, 559–563 10.1016/j.alcohol.2009.09.031 19913201 [OpenAIRE] [PubMed] [DOI]

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. Washington, DC: American Psychiatric Association

Black D. (2004). An open-label trial of bupropion in the treatment of pathological gambling. J. Clin. Psychopharmacol. 24, 108–109 10.1097/ 14709965 [OpenAIRE] [PubMed] [DOI]

Blanco C.Petkova E.Ibanez A.Sáiz-Ruiz J. (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann. Clin. Psychiatry 14, 9–15 12046642 [OpenAIRE] [PubMed]

Boothby L. A.Doering P. L. (2005). Acamprosate for the treatment of alcohol dependence. Clin. Ther. 27, 695–714 16117977 [OpenAIRE] [PubMed]

Dannon P. N.Lowengrub K.Gonopolski Y.Musin E.Kotler M. (2006). Pathological gambling: a review of phenomenological models and treatment modalities for an under recognized psychiatric disorder. Prim Care Companion J. Clin. Psychiatry 8, 334–339 17245454 [OpenAIRE] [PubMed]

Dannon P. N.Lowengrub K.Musin E.Gonopolski Y.Kotler M. (2005a). Sustained release Bupropion versus nalt rexone in the treatment of pathological gambling. J. Clin. Psychopharmacol. 25, 593–596 16282845 [OpenAIRE] [PubMed]

Dannon P. N.Lowengrub K.Gonopolski Y.Musin E.Kotler M. (2005b). Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin. Neuropharmacol. 28, 6–10 15711432 [OpenAIRE] [PubMed]

Dannon P. N.Lowengrub K.Musin E.Gonoposki Y.Kotler M. (2005c). Sustained release bupropion in the treatment of SSRI no responder pathological gamblers: pilot study and review of the literature. Therapy 2, 753–759

Dannon P. N.Lowengr ub K.Musin E.Gonopolski Y.Kotler M. (2007). 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J. Clin. Psychopharmacol. 27, 620–624 18004130 [PubMed]

Grant J. E.Kim S. W.Potenza M. N.Blanco C.Ibanez A.Stevens L.Hektner J. M.Zaninelli R. (2003). Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int. Clin. Psychopharmacol. 18, 243–249 12817159 [PubMed]

Guy W. (1976). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Publication (ADM), 76–338

Hamilton M. (1959). The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50–55 13638508 [PubMed]

Hamilton M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 23, 56–62 14399272 [OpenAIRE] [PubMed]

23 references, page 1 of 2
Any information missing or wrong?Report an Issue